Shield Therapeutics plc (STX) — Net Asset Quality Index
Shield Therapeutics plc (STX) has a Net Asset Quality Index of -23.9% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of GBX62.10 Million minus total liabilities of GBX76.96 Million yields net assets of GBX-14.86 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check financial resilience of Shield Therapeutics plc to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Shield Therapeutics plc Net Asset Quality Index Over Time (2013–2024)
This chart shows how Shield Therapeutics plc's Net Asset Quality Index has evolved across 12 annual periods from 2013 to 2024. As of June 2025, the index stands at -23.9%, representing net assets of GBX-14.86 Million against total assets of GBX62.10 Million GBX. See working capital to net assets of Shield Therapeutics plc to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Shield Therapeutics plc (2013–2024)
The table below presents the year-by-year Net Asset Quality Index for Shield Therapeutics plc from 2013 to 2024, covering 12 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see STX stock market capitalisation.
| Year | Quality Index | Net Assets (GBX) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | -2.3% | GBX-1.05 Million | GBX45.90 Million | GBX46.95 Million | ▼ -48.0 pp |
| 2023 | 45.7% | GBX22.31 Million | GBX48.80 Million | GBX26.49 Million | ▲ +21.1 pp |
| 2022 | 24.6% | GBX5.43 Million | GBX22.07 Million | GBX16.65 Million | ▼ -67.8 pp |
| 2021 | 92.4% | GBX41.03 Million | GBX44.41 Million | GBX3.38 Million | ▼ -0.7 pp |
| 2020 | 93.1% | GBX30.28 Million | GBX32.53 Million | GBX2.25 Million | ▲ +4.6 pp |
| 2019 | 88.5% | GBX32.15 Million | GBX36.32 Million | GBX4.17 Million | ▼ -4.7 pp |
| 2018 | 93.2% | GBX40.43 Million | GBX43.38 Million | GBX2.95 Million | ▲ +1.6 pp |
| 2017 | 91.6% | GBX41.21 Million | GBX44.97 Million | GBX3.76 Million | ▼ -0.8 pp |
| 2016 | 92.4% | GBX48.40 Million | GBX52.38 Million | GBX3.99 Million | ▲ +744.2 pp |
| 2015 | -651.9% | GBX-18.64 Million | GBX2.86 Million | GBX21.50 Million | ▲ +1169.3 pp |
| 2014 | -1821.1% | GBX-18.28 Million | GBX1.00 Million | GBX19.29 Million | ▼ -1527.2 pp |
| 2013 | -293.9% | GBX-6.00 Million | GBX2.04 Million | GBX8.05 Million | — |